and, most of all, to the disruption of international trade of animals and animal products (17) . The most common symptoms of BT include fever, catarrhal stomatitis, rhinitis, coronitis, enteritis, laminitis, facial and intermuscular oedema, pleural and pericardial effusion, pulmonary oedema, and necrosis of skeletal and cardiac muscle. The mortality rate can vary from 0% to 30%, but may reach 75% (9) . These symptoms are commonly seen in sheep and in some deer species but rarely in cattle and goats. Cattle, as well as goats and deer, are thought to act as a reservoir for the virus (5) .
BTV is endemic in many tropical, sub-tropical and temperate regions of the world (America, Australia, Africa and some regions of Asia), between latitudes 40°S and 53°N, during times of the year that are optimal for vector activity (11, 22) . Historically, Europe has experienced only sporadic incursions of BT, involving a single virus serotype on each occasion (10) . However, since 1998 BTV spread northwards into the Mediterranean Basin, where five BTV serotypes (1, 2, 4, 9 and 16) have been identified (12) . Climate change has been proposed as a potential driver of this northward expansion of BTV from Africa and Asia into Mediterranean Europe (15) . In the summer of 2006, for the first time, the BTV has crossed latitude 50°N and BT outbreaks caused by BTV serotype 8 occurred in North-Western Europe: the Netherlands, Belgium, Germany, France, and Luxembourg (23) . In 2007-2008, the BT situation changed for the worse, BTV8 spread to the other regions of Europe and the number of outbreaks increased rapidly (about 50 000 cases of BT were reported). Additionally, two new BTV serotypes, BTV1 and BTV6, were detected (23) . However, the implementation of BT compulsory vaccination programmes in Europe in spring 2008 resulted in reduction of BTV8 cases to 350 in 2009, 19 in 2010 and only one case of BT caused by BTV8 in 2011 in north Sardinia (Italy) (http://eubtnet.izs.it/ btnet.reports/BTV8.htlm). However, after a four year break, on 11 September 2015 an outbreak of BTV8 was confirmed again in the European Union (EU) in central France, Allier region (http://www.oie.int/wahis_2/ public/wahid.php/). The first clinical signs (facial oedema, respiratory problems and increased temperature) were observed on 21 August in a single sheep at the holding in a commune Louroux-de-Bouble. Samples tested positive from 5 out of 175 sheep and 27 out of 147 cattle. In the following weeks, the disease spread and on 06 October 2015, 45 outbreaks of 118 cases (109 in cattle and 9 in sheep) of BTV8 were confirmed in departments Allier, Puy-de-Dome, Creuse, Nievre and Cher (Fig. 1) . According to the European Commission regulation (EC) no 1266/2007 the French Ministry of Agriculture has established and implemented a restriction zone consisting of 20-km radius infected zone, protection zone (at least 100 km radius around outbreak of BT) and 150-km radius surveillance zone where there is a restriction of animal movements, active surveillance and a ban of gatherings. Additionally, the French government and livestock sectors have in place a vaccination strategy and 1.3 million doses of vaccine will be made available to prevent spread of the disease. The results of the epidemiological report suggest this is not a recent import of infected animals, but whether this is the result of unreported virus circulation (possibly in livestock or wildlife), a vaccine problem or imported infected midges is not known. More investigations will be carried out in the region and the neighbouring areas to determine the source of infection. Until the origin of disease and the extent of spread are clear, it is difficult to assess whether the recurrence of BTV8 in France signifies an increase in risk of BT in Europe (http:// www.promedmail.org/).
The current BT epidemiological situation Besides the last BTV8 outbreaks in France, the disease caused by BTV serotypes 1 and 4 is still circulating in some regions of southern and south-eastern Europe ( (18) and by March 2014, 169 BTV1 outbreaks were reported (24) . Phylogenetic studies showed that the sequences of this strain is closely related to BTV1 strain that circulating on the Mediterranean Basin and on Sardinia in 2012 (18) . Furthermore, BTV1 cases were noticed in the southwest Spain in Cáceres and Toledo provinces (14) and at the end of 2014 BTV1 has also been reported in the region of Cadiz (Andalusia) in a single (sentinel) holding presumably as a result of incursion from Morocco into Gibraltar region (http:// www.oie.int). Moreover, in November 2014, the first positive result on BTV1 was detected in sheep in Croatia in Slibenik-Knin County and later on island Lasovo in Dubrovnik -Neretva County. More recently, in April 2015, another outbreak of BTV1 has been detected in sheep in Central Dalmatia, Sibenik area (http://ec.europa.eu).
In addition to the BTV1, multiple outbreaks of BTV4 has been reported in cattle and sheep across many regions of southern Europe (Fig. 1) . On 30 May 2014, the first outbreak of BTV4 was confirmed in southern part of mainland Greece (region of Peloponnese, prefecture of Lakonia). In the period from May to July 2014, in Peloponnese and Evros regions, 125 outbreaks of BTV4 have been noticed: sixty three in Lakonia, 49 in Arkadia, 11 in Messina regions and one outbreak in Argolida and Kortinthia regions, all in sheep (http:// www.oie.int). Sequence analysis on BTV4 isolated from the latest Greek outbreaks suggest the strain present is a western lineage, but is not closely related to those from Greece and Cyprus several years ago and outbreaks could be the results of several incursions. The virus is a reassortant with the segments derived from BTV1, BTV2 and BTV4 isolates circulating in the West Mediterranean and North Africa. This mechanism of genetics recombination of genomic material is not unusual in the bluetongue virus family; gene re-assortment between BTV strains occurs frequently (http:// www.gov.uk). In total, in the whole Balkan/Peloponnese/Central Europe region, over 5500 outbreaks have been reported. Council Directive 2000/75/EC lays down control rules and measurements to combat BT in EU, including the establishment of protection and surveillance zones and a ban on animals of the susceptible species leaving those zones. Disease control measures, such as movement restrictions are in place although vaccination is not being used at present in the Eastern EU Member States for BTV4 because of a combination of vaccine availability, cost of vaccination and farmer acceptance. Vaccines are based on one of the outer proteins of the virus capsid which also determines the serotype, therefore any BTV4 vaccine would be effective for these new outbreaks. Inactivated BTV4 vaccines, as well as BTV1 and BTV2, are approved for use in the EU but there are only small, limited amounts of stocks currently available and new production and licencing would take time, depending on commercial demand. Besides, Commission Regulation The list of restriction zones in Europe as for 6 October 2015 is as follows (Fig. 2 Restriction zones have been regularly updated and these limit live animal movements but the zones will not be able to prevent spread by vectors. In some southerly regions, a mid autumn means vector numbers may remain high for some time to come, while in central Europe, for example Bulgaria, the temperature has started to drop, the first snow has been reported and this should reduce the infection pressure. Both Romania and Bulgaria are looking at the possibility of vaccination campaigns to start in 2015, once vaccine availability and financial arrangements are in place. Vaccination against BTV1 is not mandatory in Italy (except in Sardinia) and is mainly in sheep and goats or animals for movement, while Spain has both compulsory and voluntary BTV4 vaccination zones, depending on the level of risk. It is possible that in the near future the disease will spread in the Northern Europe. The population of livestock in these areas is dense and will not be protected by vaccination. Judging by the reports coming from Bulgaria and Romania, within herd prevalence is over 30% in sheep flocks, 4% in cattle herds (http://ec.europa.eu).
